Stifel Financial’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-15,513
Closed -$622K 3375
2023
Q2
$622K Sell
15,513
-84
-0.5% -$3.37K ﹤0.01% 2390
2023
Q1
$637K Sell
15,597
-143
-0.9% -$5.84K ﹤0.01% 2373
2022
Q4
$608K Sell
15,740
-171
-1% -$6.6K ﹤0.01% 2362
2022
Q3
$847K Buy
15,911
+1,071
+7% +$57K ﹤0.01% 2084
2022
Q2
$866K Buy
14,840
+426
+3% +$24.9K ﹤0.01% 2107
2022
Q1
$1.1M Sell
14,414
-12,094
-46% -$923K ﹤0.01% 2047
2021
Q4
$1.6M Sell
26,508
-2,317
-8% -$139K ﹤0.01% 1787
2021
Q3
$1.61M Buy
28,825
+2,889
+11% +$162K ﹤0.01% 1728
2021
Q2
$1.57M Buy
25,936
+12,785
+97% +$776K ﹤0.01% 1776
2021
Q1
$922K Sell
13,151
-189
-1% -$13.3K ﹤0.01% 2043
2020
Q4
$798K Sell
13,340
-68
-0.5% -$4.07K ﹤0.01% 2014
2020
Q3
$806K Sell
13,408
-7,897
-37% -$475K ﹤0.01% 1780
2020
Q2
$1.12M Buy
21,305
+13,144
+161% +$690K ﹤0.01% 1485
2020
Q1
$273K Sell
8,161
-6,089
-43% -$204K ﹤0.01% 2243
2019
Q4
$642K Sell
14,250
-874
-6% -$39.4K ﹤0.01% 2106
2019
Q3
$580K Buy
15,124
+767
+5% +$29.4K ﹤0.01% 2093
2019
Q2
$629K Sell
14,357
-1,974
-12% -$86.5K ﹤0.01% 2084
2019
Q1
$625K Buy
16,331
+2,904
+22% +$111K ﹤0.01% 1936
2018
Q4
$578K Sell
13,427
-866
-6% -$37.3K ﹤0.01% 1866
2018
Q3
$703K Buy
14,293
+5,608
+65% +$276K ﹤0.01% 1911
2018
Q2
$280K Sell
8,685
-1,039
-11% -$33.5K ﹤0.01% 2343
2018
Q1
$304K Sell
9,724
-1,118
-10% -$35K ﹤0.01% 2243
2017
Q4
$494K Buy
10,842
+1,475
+16% +$67.2K ﹤0.01% 1922
2017
Q3
$353K Buy
+9,367
New +$353K ﹤0.01% 2079
2016
Q1
Sell
-3,626
Closed -$278K 2338
2015
Q4
$278K Buy
+3,626
New +$278K ﹤0.01% 1955
2015
Q3
Sell
-4,300
Closed -$304K 2334
2015
Q2
$304K Sell
4,300
-6,296
-59% -$445K ﹤0.01% 1948
2015
Q1
$942K Buy
10,596
+1,022
+11% +$90.9K 0.01% 1316
2014
Q4
$850K Sell
9,574
-198
-2% -$17.6K ﹤0.01% 1348
2014
Q3
$947K Sell
9,772
-3,372
-26% -$327K 0.01% 1161
2014
Q2
$1.21M Sell
13,144
-1,804
-12% -$166K 0.01% 1012
2014
Q1
$1.05M Buy
+14,948
New +$1.05M 0.01% 1049